Crinetics Pharmaceuticals Inc (CRNX)
51.38
-0.53
(-1.02%)
USD |
NASDAQ |
May 17, 16:00
51.38
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
Date | Value |
---|---|
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
--
Maximum
Dec 2021
--
Average
--
Median
Dec 2021
Debt to Equity Ratio Benchmarks
Catalyst Pharmaceuticals Inc | 0.00 |
Geron Corp | 0.2399 |
Madrigal Pharmaceuticals Inc | -- |
PTC Therapeutics Inc | -0.3183 |
Syndax Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 978.15M |
Total Liabilities (Quarterly) | 103.22M |
Shareholders Equity (Quarterly) | 874.93M |
Current Ratio | 17.72 |